Abstract: Objectives - To develop recommendations for the management of rheumatic and musculoskeletal diseases (RMDs) during the COVID-19 pandemic. Method - A task force comprising of 25 rheumatologists from the 5 regions of the continent was formed and operated through a huband- spoke model with a central working committee (CWC) and 4 subgroups. The subgroups championed separate scopes of the clinical questions and formulated preliminary statements of recommendations which were processed centrally in the CWC. The CWC and each subgroup met by several virtual meetings, and two rounds of voting were conducted on the drafted statements of recommendations. Votes were online-delivered and recommendations were pruned down according to predefined criteria. Each statement was rated between 1 and 9 with 1–3, 4–6 and 7–9 representing disagreement, uncertainty and agreement, respectively. The levels of agreement on the statements were stratified as low, moderate or high according to the spread of votes.A statement was retired if it had a mean vote below 7 or a ‘low’ level of agreement.
Authors: Richard Oluyinka Akintayo, Rachid Bahiri, Yasser El Miedany, Hakeem Olaosebikan, Asgar Ali Kalla, Adewale Olukayode Adebajo, Angela Nyangore Migowa, Samy Slimani, Ouma Devi Koussougbo, Ben Abdelghani Kawther, Akpabio Akanimo Akpabio, Imad Ghozlani, Dzifa Dey, Waleed A. Hassan, Nimmisha Govind, Kavita Makan, Abdelgaffar Mohamed, Eugene Kalman Genga, Mohamed Khattry Ahmed Ghassem, Mohamed Mortada, Wafa Hamdi, Moudjib O. Wabi, Mohammed Tikly, Madeleine Ngandeu-Singwe, Christian Scott
First Posted: July 8, 2020Download PDF
Abstract: This chapter describes the musculoskeletal (MSK) context in children and young people as an important contributor to the global non-communicable disease burden. Through selected MSK conditions, we describe the impact on patients, families and communities and highlight the challenges that need to be addressed. We focus on opportunities for better working together and describe exemplar initiatives to raise awareness, workforce capacity building, models of care and research agendas to have a greater global context.
Authors: Helen E. Foster, Christiaan Scott, Carl J. Tiderius, Matthew B. Dobbs, Elizabeth Ang, Sirirat Charuvanij, Wendy Costello, Marja Kinnunen, Laura B. Lewandowski, Angela Migowa, Simon R. Stones, Soamarat Vilaiyuk, Kate Webb
First Posted: July 26, 2020Download PDF
Abstract: The onset of the COVID-19 pandemic has led to far-reaching changes in the delivery of healthcare services across Africa. A number of drugs used in the management of rheumatic diseases have been touted to have roles to play in the treatment and/or exacerbation of COVID-19 symptoms and this has resulted in significant changes in the practice of rheumatology. The global rheumatology community has risen to this challenge by demonstrating collaborative partnership, resulting in the establishment of the global rheumatology registry to collect data on rheumatic patients infected with COVID-19.
Authors: Richard Oluyinka Akintayo, Akpabio Akpabio, Asgar Kalla, Dzifa Dey, Angela Migowa, Hakeem Olaosebikan, Rachid Bahiri, Yasser El Miedany, Djohra Hadef, Wafa Hamdi, Omondi Oyoo, Samy Slimani, Abubakar Yerima, Yassmin Taha, Adewale Adebajo, Olufemi Adelowo, Mohammed Tikly, Imad Ghozlani, Kawther Ben Abdelghani, Nermeen Ahmed Fouad, Doaa Mosad, Dalia El Mikkawy, Mohamed Hassan Abu-Zaid, Rasha A Abdel-Magied
First Posted: July 1, 2020Download PDF